Abstract
As increasing numbers of people are identified at risk for multi-factorial diseases, questions of how to assess, communicate and manage genetic risk will be critical from health services and policy perspectives. However, there is currently no evidence-based genetic risk assessment and management framework to assist policy makers, clinicians and other stakeholders. A comprehensive psychosocial framework for risk assessment and management has been developed in the context of security hazards or threats. In an adaptation of that model, we present the Psychosocial Genetics Risk Assessment and Management framework (PG-RAM). It offers principles to enhance the integration of evidence-based best practices into genetics health services, as well as to identify issues, knowledge and gaps. The framework identifies the core elements of the situation, effects, population and interventions, all spanning several phases of genetic disorders. The framework provides an excellent starting point for knowledge syntheses in the context of genetic risk and could serve as the conceptual basis for practical tool development to guide healthcare professionals and decision makers in preparing for and responding to the psychosocial aspects of genetic risk.
Similar content being viewed by others
References
Almqvist, E., Bloch, M., Brinkman, R., Craufurd, D., & Hayden, M. (1999). A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington’s disease. American Journal of Human Genetics, 64, 1293–1304.
Baum, A., Friedman, A., & Zakowski, S. (1997). Stress and genetic testing for disease risk. Health Psychology, 16, 8–19.
Binedell, J., & Soldan, J. (1997). Nonparticipation in Huntington’s disease predictive testing: reasons for caution in interpreting findings. Journal of Genetic Counseling, 6, 419–432.
Blaine, S., & Carroll, J. (2002). Genetic screening for hereditary breast/ovarian and colorectal cancers. The Foundation for Medical Practice Education, 10, 1–9.
Bottorff, J., Ratner, P., Richardson, C., Balneaves, L., McCullum, M., Hack, T., et al. (2003). The influence of question wording on assessments of interest in genetic testing for breast cancer risk. Psycho-Oncology, 12, 720–728.
Bottorff, J., Blaine, S., Carroll, J., Esplen, M., Evans, J., Nicolson Klimek, M., et al. (2005). The educational needs and professional roles of Canadian physicians and nurses regarding genetic testing and adult onset hereditary disease. Community Genetics, 8, 80–87.
Braithwaite, D., Emery, J., Walter, F., Prevost, A., & Sutton, S. (2006). Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Familial Cancer, 5, 61–75.
Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: a systematic review. European Journal of Human Genetics, 2000(8), 731–38.
Cameron, L., & Diefenbach, M. (2001). Responses to information about psychosocial consequences of genetic testing for breast cancer susceptibility: influences of cancer worry and risk perceptions. Journal of Health Psychology, 6, 47–59.
Codori, A., Petersen, G., Miglioretti, D., Larkin, E., Bushey, M., Young, C., et al. (1999). Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology, Biomarkers & Prevention, 8, 345–351.
Codori, A., Waldeck, T., Petersen, G., Miglioretti, D., Trimbath, J., & Tillery, M. (2005). Genetic counseling outcomes: perceived risk and distress after counseling for hereditary colorectal cancer. Journal of Genetic Counseling, 14, 119–132.
Collins, F., & McKusick, V. (2001). Implications of the human genome project for medical science. Journal of the American Medical Association, 285, 540–544.
Cormier, L., Valeri, A., Azzouzi, R., Fournier, G., Cussenot, O., Berthon, P., et al. (2002). Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. The Prostate, 51, 276–285.
Cox, S., & McKellin, W. (1999). There’s this thing in our family: predictive testing and the construction of risk for Huntington Disease. Sociology of Health & Illness, 21, 622–646.
Croyle, R., & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. Journal of the National Cancer Institute. Monographs, 25, 59–66.
Donovan, K., & Tucker, D. (2000). Knowledge about genetic risk for breast cancer and perception of genetic testing in a sociodemographically diverse sample. Journal of Behavioral Medicine, 23, 15–36.
Emery, J., Watson, E., Rose, P., & Andermann, A. (1999). A systematic review of the literature exploring the role of primary care in genetic services. Family Practice, 16, 426–445.
Etchegary, H. (2004). Psychological aspects of predictive genetic test decisions: what do we know so far? Analyses of Social Issues and Public Policy, 4, 13–31.
Etchegary, H., Cappelli, M., Potter, B., Vloet, M., Graham, I., Walker, M., et al. (2010). Attitude and knowledge about genetics and genetic testing. Public Health Genomics, 13(2), 80–88.
Gaskell, G., Allum, N., Bauer, M., Durant, J., Allansdottir, A., Bonfadelli, H., et al. (2000). Biotechnology and the European public. Nature Biotechnology, 18, 935–938.
Haddow, J., & Palomaki, G. (2004). ACCE: A model process for evaluating data on emerging genetic tests. In M. Khoury, J. Little, & W. Burke (Eds.), Human genome epidemiology (pp. 122–145). Oxford: Oxford University Press.
Hadley, D., Jenkins, J., Dimond, E., de Carvalho, M., Kirsch, I., & Palmer, C. (2004). Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology, 22, 39–44.
Hallowell, N. (1999). Doing the right thing: genetic risk and responsibility. Sociology of Health & Illness, 21, 597–621.
Henderson, B., & Maguire, B. (1998). Lay representations of genetic disease and predictive testing. Journal of Health Psychology, 3, 233–241.
Heshka, J., Palleschi, C., Howley, H., Wilson, B., & Wells, P. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine, 10, 19–32.
Jones, I., Scourfield, J., McCandless, F., & Craddock, N. (2002). Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. Journal of Affective Disorders, 71, 189–193.
Kenen, R., Ardern-Jones, R., & Eeles, R. (2003). Living with chronic risk: healthy women with a family history of breast/ovarian cancer. Health, Risk and Society, 5, 315–331.
Khoury, M. (2003). Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genetics in Medicine, 5, 261–268.
Lee, R., Kmet, L., Cook, L., Lorenzetti, D., Godlovitch, G., & Einsiedal, E. (2005). Risk assessment for inherited susceptibility to cancer: a review of the psychosocial and ethical dimensions. Genetic Testing, 9, 66–79.
Lemyre, L., Clement, L., Corneil, W., Craig, L., Boutette, P., Tyshenko, M., et al. (2008). A psychosocial risk assessment and management framework to enhance response to CBRN terrorism threats and attacks. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 3, 316–330.
Lerman, C., Hughes, C., Croyle, R., Main, D., Durham, C., Snyder, L., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA 1/2 testing. Preventive Medicine, 31, 75–80.
Lerman, C., Croyle, R., Tercyak, K., & Hamann, H. (2002). Genetic testing: psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70, 784–797.
Lim, J., Macluran, M., Price, M., Bennett, B., & Butow, P. (2004). Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. Journal of Genetic Counseling, 13, 115–133.
Marteau, T., & Croyle, R. (1998). Psychological responses to genetic testing. British Medical Journal, 316, 693–696.
McCabe, L., & McCabe, E. (2008). Expanded newborn screening: implications for genomic medicine. Annual Review of Medicine, 59, 163–175.
McGuire, A., Cho, M., & Caulfield, T. (2007). The future of personalized genomics. Science, 317, 1687.
McIntosh, A., Shaw, C., & Evans, G. (2004). Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer. London: National Collaborating Centre for Primary Care: University of Sheffield.
Meiser, B. (2005). Psychological impact of genetic testing for cancer suceptibility: an update of the literature. Psycho-oncology, 14, 1060–74.
Meiser, B., & Dunn, S. (2000). Psychological impact of genetic testing for Huntington’s disease: an update of the literature. Journal of Neurology, Neurosurgery and Psychiatry, 69, 574–578.
Morren, M., Rijken, M., Baanders, A., & Bensing, J. (2007). Perceived genetic knowledge, attitudes towards genetic testing, and the relationship between these among patients with a chronic disease. Patient Education and Counseling, 65, 197–204.
Paling, J. (2003). Strategies to help patients understand risks. British Medical Journal, 327, 745–748.
Qureshi, N., Wilson, B., Santaguida, P., Little, J., Carroll, J., Allanson, J., et al. (2009). Family history and improving health. Agency for Healthcare Research and Quality. Accessed October 7, 2009: http://www.ahrq.gov/downloads/pub/evidence/pdf/famhistory/famhimp.pdf.
Rolland, J. (1994). Families, illness, and disability: An integrative treatment model. New York: Basic Books.
Rolland, J. (1999). Commentary: families and genetic fate: a millennial challenge. Families, Systems & Health, 17, 123–132.
Rolland, J., & Williams, J. (2005). Toward a biopsychosocial model for 21rst century genetics. Family Process, 44, 3–24.
Sanderson, S., Wardle, J., & Michie, S. (2005). The effects of a genetic information leaflet on public attitudes towards genetic testing. Public Understanding of Science, 14, 213–224.
Sheehy, H., Legault, M., & Ireland, D. (1998). Consumers and biotechnology: a synopsis of survey and focus group research. Journal of Consumer Policy, 21, 359–386.
Singer, E., Corning, A., & Lamias, M. (1998). Trends: genetic testing, engineering, and therapy: awareness and attitudes. Public Opinion Quarterly, 62, 633–664.
Street, E., & Soldan, J. (1998). A conceptual framework for the psychosocial issues faced by families with genetic conditions. Families, Systems, & Health, 16, 217–232.
Struewing, J., Lerman, C., Kase, R., Giambarresi, T., & Tucker, M. (1995). Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology, Biomarkers & Prevention, 4, 169–173.
Trepanier, A., Ahrens, M., McKinnon, W., Peters, J., Stopfer, J., Grumet, S., et al. (2006). Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. Journal of Genetic Counseling, 13, 83–114.
Wilson, B. (2006). The challenge of developing evidence-based genetics health care in practice. Familial Cancer, 5, 55–59.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Etchegary, H., Lemyre, L. & Wilson, B. Bringing the Social into Genetics: The Psychosocial Genetics Risk Assessment and Management Framework (PG-RAM). Curr Psychol 29, 171–187 (2010). https://doi.org/10.1007/s12144-010-9085-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12144-010-9085-7